References
- Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295(19):2275–85.
- Lane MA, McDonald JR, Zeringue AL, Caplan L, Curtis JR, Ranganathan P, et al. TNF-a antagonist use and risk of hospi-talization for infection in a national cohort of veterans with rheumatoid arthritis. Medicine (Baltimore). 2011;90(2):139–45.
- Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necro-sis factor antagonists. Clin Infect Dis. 2004;38(9):1261–5.
- Ross JJ, Saltzman CL, Carling P, Shapiro DS. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis. 2003;36(3): 319–27.
- Smith SM, Lee EY, Cobbs CJ, Eng RH. Unusual features of arthritis caused by Candida parapsilosis. Arch Pathol Lab Med. 1987;111(1):71–3.
- De Clerck L, Dequeker J, Westhovens R, Hauglustaine D. Can-dida parapsilosis in a patient receiving chronic hemodialysis. J Rheumatol. 1988;15(2):372–4.
- Katzenstein D. Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome. Arthritis Rheum. 1985;28(12):1421–4.
- Wada M, Baba H, Imura S. Prosthetic knee Candida parapsilosis infection. J Arthroplasty. 1998;13(4):479–82.
- Mathews CJ, Kingsley G, Field M, Jones A, Weston VC, Phillips M, et al. Management of septic arthritis: a systematic review. Ann Rheum Dis. 2007;66(4):440–5.
- Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc. 2008;83(2):181–94.
- Curtis JR, Xi J, Patkar N, Xie A, Saag KG, Martin C. Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum. 2007;56(12): 4226–7.
- Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, et al. Time-dependent increase in risk of hospitali-sation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis. 2007;66(10):1339–44.
- Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol. 1994;32(2):452–6.
- Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Dis-eases Society of America. Clin Infect Dis. 2009;48(5):503–35.